Indications And Usage
Topical anesthetic for use on oral mucosa
The following Structured Product Label (SPL) was submitted to the FDA by Dentsply Llc. Professional Division Trading As "sultan Healthcare" for the product Topex (NDC 0699-3100). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding indications and usage, dosage and administration, dosage forms and strengths, contraindications, warnings and precautions, overdosage, storage and handling, principal display panel - carton, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Topical anesthetic for use on oral mucosa
Attach disposable straw to the spray valve. Spray directly on mucosa to achieve topical anesthesia.
Each gram of Topex 20% benzocaine topical anesthetic spray contains between 180-220 mg benzocaine. Each metered spray delivers approximately 6.8 mg of benzocaine.
Should not be used in individuals with a known sensitivity to benzocaine or PABA.
METHEMOGLOBINEMIA WARNING:
Use of this product may cause methemoglobinemia, a rare but serious condition that must be treated promptly because it reduces the amount of oxygen carried in blood. Stop use and seek immediate medical attention if the patient in your care develops:
• Not for use in children under 2 years of age.
• Keep out of reach of children.
In case of overdose, get medical help or contact a Poison Control Center right away.
Store between 59°-86°F (15°-30°C).
* Please review the disclaimer below.